Glenmark gets approval from Australian regulator to commercialise Ryaltris

Ryaltris is a new fixed dose combination nasal spray of an antihistamine and a steroid indicated for treatment of symptoms associated with allergic rhinitis and rhinoconjunctivitis in patients over 12 years of age in Australia.

from Moneycontrol Business News https://ift.tt/2s4Md3k